title: The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study.
abstract: We have used flow cytometry to study the mechanism of cytotoxic action of a series of ammine/amine Pt(IV) dicarboxylates [ammine diacetatodichloro(cyclohexylamine) platinum(IV), JM216; ammine dibutyratodichloro(cyclohexylamine)platinum(IV), JM221; ammine diacetatodichloro(propylamine)platinum(IV), JM223; ammine dibenzoatodichloro(propylamine)platinum(IV), JM244]. JM216 has been shown to have clinical potential and has recently entered phase II trials. All the compounds caused a slowdown in S-phase transit followed by a block in G2. Cells died either through apoptosis (largely during S-phase) or by failing to overcome the G2 block (some days after treatment). In G2, the cells either divided or enlarged and died. At equitoxic doses, JM216 showed the most apoptotic cells and had the most platinum bound to the DNA; JM244 showed the fewest apoptotic cells and had the least platinum bound to DNA. We suggest that whether apoptosis was triggered or not was governed by the total amount of Pt bound to the DNA; the type of lesion was more important in determining whether a cell became blocked in G2.
authors.affiliation: Cancer Research Campaign Centre for Cancer Therapeutics, Institute of Cancer Research: Royal Cancer Hospital, Sutton, UK.
authors.forename: M G
authors.initials: MG
authors.lastname: Ormerod
authors.forename: R M
authors.initials: RM
authors.lastname: Orr
authors.forename: C F
authors.initials: CF
authors.lastname: O'Neill
authors.forename: T
authors.initials: T
authors.lastname: Chwalinski
authors.forename: J C
authors.initials: JC
authors.lastname: Titley
authors.forename: L R
authors.initials: LR
authors.lastname: Kelland
authors.forename: K R
authors.initials: KR
authors.lastname: Harrap
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D002453:Cell Cycle / Q000187:drug effects / Q000502:physiology; D002470:Cell Survival / Q000187:drug effects; D004273:DNA, Neoplasm / Q000737:chemistry; D005434:Flow Cytometry / Q000379:methods*; D007939:Leukemia L1210 / Q000188:drug therapy / Q000235:genetics; D051379:Mice; D009944:Organoplatinum Compounds / Q000737:chemistry / Q000494:pharmacology* / Q000633:toxicity*; D010984:Platinum / Q000493:pharmacokinetics
chemical_list: D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; C103115:JM 223; D009944:Organoplatinum Compounds; C075438:JM 221; C075439:JM 244; D010984:Platinum; C081294:satraplatin